Current status of and strategies for hepatitis C control in South Korea
Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim
Clin Mol Hepatol. 2017;23(3):212-218.   Published online 2017 Sep 19     DOI: https://doi.org/10.3350/cmh.2017.0105
Citations to this article as recorded by Crossref logo
Epidemiology of liver cancer in South Korea
Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2018; 24(1): 1.     CrossRef
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
Hye Won Lee, Se Rim Oh, Dong Yun Kim, Yechan Jeong, Seungtaek Kim, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Gut and Liver.2018; 12(3): 324.     CrossRef
Updates on Cancer Epidemiology in Korea, 2018
Sun-Seog Kweon
Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population
Kyung-Ah Kim, Wankyo Chung, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook-Hyang Jeong
Liver International.2018;[Epub]     CrossRef